Cardiovascular protection with a long-acting glp-1 receptor agonist liraglutide: an experimental update

HIGHLIGHTS

• who: Collin Vandemark et al. from the Research Laboratory, Mercer University School of Medicine, Savannah, GA, USA have published the article: Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update, in the Journal: Molecules 2023, 28, 1369. of /2023/
• what: The aim of this review is to compile the recent outcomes-based studies and provide an overview the protection from liraglutide against Ang II- and pressure overload-mediated deleterious effects on the heart. The laboratory has a long-standing interest in the investigation of liraglutide on Ang II-induced cardiac . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.